Fulminant Herpes Simplex Virus Type I Encephalitis Despite Maximal Medical Therapy.

Area of Science:

• Neurology
• Infectious Diseases

Background:

• Herpes simplex-1 virus encephalitis (HSE) is a leading cause of sporadic encephalitis in the US.
• Historically, HSE has led to severe neurological damage, cerebral edema, and status epilepticus.
• While antiviral therapies have improved management, high morbidity and mortality persist.

Observation:

• A case study of a 19-year-old female diagnosed with HSE.
• The patient received standard acyclovir therapy at recommended dosages and duration.
• Despite treatment, her clinical condition deteriorated significantly.

Findings:

• Standard acyclovir therapy was insufficient for this patient's HSE.
• The patient required a combination of multiple antiviral therapeutics.
• Steroid therapy was also administered as part of her treatment regimen.

Implications:

• This case highlights the need for tailored treatment approaches in HSE.
• Prompt initiation of antiviral therapy remains critical for managing HSE.
• Further research into advanced therapeutic strategies for severe HSE cases is warranted.